Abstract
We report a 14-year-old patient with Japanese glycogen storage disease I (GSD-I) who was found to have proteinuria. Renal biopsy revealed massive tubular atrophy and interstitial fibrosis with mononuclear cell infiltration, but the glomeruli were almost normal. The epithelial cells of tubules contained periodic acid-Schiff-positive glycogen deposits digested by diastase. In an immunohistological study, transforming growth factor (TGF)-β expression was increased in tubular epithelial cells compared with a normal control kidney specimen. These data suggest that increased TGF-β expression is involved in the pathophysiology of renal interstitial fibrosis in a patient with GSD-I.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00467-004-1456-6/MediaObjects/s00467-004-1456-6fhb1.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00467-004-1456-6/MediaObjects/s00467-004-1456-6fhb2a-b.jpg)
References
Chen YT (2000) Glycogen storage diseases. In: Scriver, Beaudet, Sly, Valle (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw-Hill, New York, p 1533
Chen YT (1991) Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment. Pediatr Nephrol 5:71–76
Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498–1509
Burchell A (1992) The molecular basis of the type I glycogen storage diseases. Bioassays 14:395–400
Lee PJ, Dalton RN, Shah V, Hindmarsh PC, Leonard JV (1995) Glomerular and tubular function in glycogen storage disease. Pediatr Nephrol 9:705–710
Nath KA (1992) Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1-17
Struts F, Müller GA (1997) Renal fibrogenesis and progression. In: Neilson EG, Couser WC (eds) Immunologic renal diseases. Lipincott-Raven, Philadelphia, pp 705–726
Knecht A, Fine LG, Kleinman KS, Rodemann HP, Muller GA, Wood DD, Norman JT (1991) Fibroblasts of rabbit kidney in culture. II. Paracrine stimulation of papillary fibrobrasts by PDGF. Am J Physiol 261:F292–F199
Border WA, Noble NA (1994) Mechanisms of disease. Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286–1292
Eddy AA, Giachelli CM, McCulloch L, Liu E (1995) Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47:1546–1557
Grinnell F, Ho CH (2002) Transforming growth factor β stimulates fibroblast-collagen matrix contraction by different mechanisms in mechanically loaded and unloaded matrices. Exp Cell Res 273:248–255
**de K, Nikolic-Paterson DJ, Huang XR, Sakai H, Kurokawa K, Atkins RC, Lan HY (2001) Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 38:761–769
Phillips AO, Steadman R, Morrisey K, Williams JD (1997) Polarity of stimulation and secretion of transforming growth factor-beta 1 by cultured proximal tubular cells. Am J Pathol 150:1101–1111
Border WA, Nobel NA (1997) TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int 51:1388–1396
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Urushihara, M., Kagami, S., Ito, M. et al. Transforming growth factor-β in renal disease with glycogen storage disease I. Pediatr Nephrol 19, 676–678 (2004). https://doi.org/10.1007/s00467-004-1456-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-004-1456-6